207 related articles for article (PubMed ID: 35448977)
1. ASD with ADHD vs. ASD and ADHD alone: a study of the QbTest performance and single-dose methylphenidate responding in children and adolescents.
Stevanovic D; Wentz E; Nasic S; Knez R
BMC Psychiatry; 2022 Apr; 22(1):282. PubMed ID: 35448977
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Methylphenidate on QbTest Performance of Children with ADHD: A Retrospective Clinical Study.
Knez R; Stevanovic D; Nasic S; Doric A; Wentz E
Neuropsychiatr Dis Treat; 2021; 17():19-32. PubMed ID: 33447036
[TBL] [Abstract][Full Text] [Related]
3. Effects of one single-dose methylphenidate compared to one single-dose placebo on QbTest performance in adults with untreated ADHD: a randomized controlled trial.
Jansson L; Löhman M; Östlund M; Domingo B
BMC Psychiatry; 2023 Oct; 23(1):762. PubMed ID: 37848887
[TBL] [Abstract][Full Text] [Related]
4. The Structure and Diagnostic Accuracy of the QbTest in Pediatric ADHD: A Retrospective Clinical Study.
Stevanovic D; Nasic S; Doric A; Wentz E; Knez R
J Atten Disord; 2023 Sep; 27(11):1296-1305. PubMed ID: 37199293
[TBL] [Abstract][Full Text] [Related]
5. Dose-Response Effects of Long-Acting Liquid Methylphenidate in Children with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study.
Kim SJ; Shonka S; French WP; Strickland J; Miller L; Stein MA
J Autism Dev Disord; 2017 Aug; 47(8):2307-2313. PubMed ID: 28474229
[TBL] [Abstract][Full Text] [Related]
6. Processing speed as a marker to stimulant effect in clinical sample of children with high functioning autism spectrum disorder.
Peled J; Cassuto H; Berger I
Nord J Psychiatry; 2020 Apr; 74(3):163-167. PubMed ID: 31686565
[No Abstract] [Full Text] [Related]
7. Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
Pearson DA; Santos CW; Aman MG; Arnold LE; Lane DM; Loveland KA; Mansour R; Ward AR; Casat CD; Jerger S; Schachar RJ; Bukstein OG; Cleveland LA
J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):414-426. PubMed ID: 32644833
[No Abstract] [Full Text] [Related]
8. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
9. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
10. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
11. Protocol investigating the clinical utility of an objective measure of attention, impulsivity and activity (QbTest) for optimising medication management in children and young people with ADHD 'QbTest Utility for Optimising Treatment in ADHD' (QUOTA): a feasibility randomised controlled trial.
Hall CL; James M; Brown S; Martin JL; Brown N; Selby K; Clarke J; Vijayan H; Guo B; Sayal K; Hollis C; Groom MJ
BMJ Open; 2018 Feb; 8(2):e021104. PubMed ID: 29453304
[TBL] [Abstract][Full Text] [Related]
12. A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorder.
Joshi G; DiSalvo M; Wozniak J; Ceranoglu TA; Yule A; Surman C; Fried R; Galdo M; Hoskova B; Belser A; Biederman J
World J Biol Psychiatry; 2020 Apr; 21(4):274-290. PubMed ID: 31607204
[No Abstract] [Full Text] [Related]
13. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
[TBL] [Abstract][Full Text] [Related]
14. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH
J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD).
DeVito EE; Blackwell AD; Clark L; Kent L; Dezsery AM; Turner DC; Aitken MR; Sahakian BJ
Psychopharmacology (Berl); 2009 Jan; 202(1-3):531-9. PubMed ID: 18818905
[TBL] [Abstract][Full Text] [Related]
16. Remission in children and adolescents diagnosed with attention-deficit/hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidate.
Chou WJ; Chen SJ; Chen YS; Liang HY; Lin CC; Tang CS; Huang YS; Yeh CB; Chou MC; Lin DY; Hou PH; Wu YY; Liu HJ; Huang YF; Hwang KL; Chan CH; Pan CH; Chang HL; Huang CF; Hsu JW
J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):215-25. PubMed ID: 22537358
[TBL] [Abstract][Full Text] [Related]
17. Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.
Pearson DA; Santos CW; Aman MG; Arnold LE; Casat CD; Mansour R; Lane DM; Loveland KA; Bukstein OG; Jerger SW; Factor P; Vanwoerden S; Perez E; Cleveland LA
J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):337-51. PubMed ID: 23782128
[TBL] [Abstract][Full Text] [Related]
18. High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder.
Golubchik P; Shalev L; Tsamir D; Manor I; Weizman A
Int Clin Psychopharmacol; 2019 May; 34(3):138-142. PubMed ID: 30640748
[TBL] [Abstract][Full Text] [Related]
19. Continuous Performance Test Is Sensitive to a Single Methylphenidate Challenge in Preschool Children With ADHD.
Peskin M; Sommerfeld E; Basford Y; Rozen S; Zalsman G; Weizman A; Manor I
J Atten Disord; 2020 Jan; 24(2):226-234. PubMed ID: 27887009
[No Abstract] [Full Text] [Related]
20. Objective QbTest and subjective evaluation of stimulant treatment in adult attention deficit-hyperactivity disorder.
Bijlenga D; Jasperse M; Gehlhaar SK; Sandra Kooij JJ
Eur Psychiatry; 2015 Jan; 30(1):179-85. PubMed ID: 25172155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
